With all the domain knowledge – Technical and Financial, under one platform, the team uses appropriate valuation methodology to assist clients in their investment decision.
- Business evaluation of start-up pharma companies
- Third-party Financial Due Diligence
- Market models of launched products to assess commercial potential of NCE / NBE/ NME/ GenericsÂ
- Investment opportunity assessment of sub sectors, API, formulations
- Assist investment banks in identifying opportunities in Pharma and co-execute the projects
- Identifying close-fitting synergies, operational efficiencies, and productivity in the M&A deals